Actively Recruiting
Community-based Implementation of Online EmReg
Led by Icahn School of Medicine at Mount Sinai · Updated on 2025-04-06
50
Participants Needed
1
Research Sites
201 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a hybrid type III implementation-effectiveness trial; this study design blends elements of implementation and clinical effectiveness research, with the primary aim of determining the utility of an implementation strategy and a secondary aim of assessing clinical outcomes associated with the implementation trial. Consistent with best practices for this type of design, the study team will conduct a randomized test of the effect of implementation strategy on effective delivery of the Online EmReg intervention in clinical practice. Specifically, the study team will compare Standard Training (a 3-hour on-demand training workshop) to Extended Training, (a 3-hour on-demand training workshop with 3 months of bi-weekly consultation). The research team's primary aim is to determine the optimal strategy to train clinicians in effectively delivering Online EmReg, and secondary aim is to assess patient improvement per clinician-administered DERS. Outcome measures will be assessed via self-report surveys, performance evaluations (via role-plays), and tracked clinician participation and fidelity. Study participation is expected to last up to 18 months.
CONDITIONS
Official Title
Community-based Implementation of Online EmReg
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Licensed psychologist, social worker, or mental health counselor
- Training and experience in CBT, the framework for EmReg
- Experience working with people with TBI
- Experience providing group treatment
- A computer and internet to conduct group treatment via telehealth
- Actively treating 3 or more patients with TBI appropriate for EmReg
- Willing to complete training, consultation, role-plays, and data collection
- Not previously trained in EmReg
- Proficient in English
You will not qualify if you...
- Not willing to conduct group treatment via telehealth
- Non-English speaking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
Research Team
E
Emily Blunt, BA
CONTACT
A
Annell Ovalles, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here